Skip to content

Cosmetic results for patients with breast cancer operated with bilateral reduction mammoplasty

Cosmetic outcome and symmetry for patients who have undergone bilateral therapeutic mammoplasty for breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN82786416
Enrollment
150
Registered
2019-11-08
Start date
2018-10-01
Completion date
Unknown
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cosmetic outcome after breast cancer surgery Surgery

Interventions

The patients eligible for inclusion is all patients operated with bilateral therapeutic mammoplasty between 2011 and until August 2018, the patients were identified and the data was retrospectively co

Sponsors

Region Skåne
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: All patients operated with bilateral therapeutic mammoplasty between 2011 and August 2018 in Centralsjukhuset Kristianstad

Exclusion criteria

Exclusion criteria: 1. Patients who had a mastectomy before the 1-year postoperative follow-up 2. Patients who had a nipple removed during the surgery due to tumor location 3. Patients where the postoperative 1-year photos were missing 4. Patients who died before the 1-year follow-up

Design outcomes

Primary

MeasureTime frame
1. Cosmetic outcome measured using BCCT.core score on a 4-grade scale 1-year postoperatively 2. Symmetry measurements from BCCT.core preoperative and 1-year postoperative 3. Patient's cosmetic scores on a scale of 1-10 at 1-year postoperatively 4. Surgeon's cosmetic scores on a scale of 1-10 at 1-year postoperatively

Secondary

MeasureTime frame
1. Complications documented for each breast separately according to Clavien-Dindo classification 2 weeks postoperatively and 1 year postoperatively 2. Breast size in ml measured using plastic breast cups preoperatively 3. Breast measurements in cm measured using measuring tape preoperatively 4. Percentage of breast excised during surgery measured by dividing the weight of the breast tissue excised in surgery with the weight of the breast 5. Axillary dissection in surgery, measured by if there was an axillary clearance or not 6. Tumor characteristics in pathology answers measured using pathology reports 2 weeks postoperatively

Countries

Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026